• Tidak ada hasil yang ditemukan

links.lww.com/JAAOS/A166

N/A
N/A
Protected

Academic year: 2024

Membagikan "links.lww.com/JAAOS/A166"

Copied!
5
0
0

Teks penuh

(1)

Supplemental Table 1. Quality Measures and Candidate Quality Measures

Source NQS

Domain

Structure, Process, or

Outcome Measure Endorsement/Steward Relevance

Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Process Review health history to address risk factors for LEND; Blood Glucose levels (HgbA1c,

Fasting, 2 hour post prandial). WOCN General

Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Process Review health history to address risk factors

for LEND; Renal function: BUN, Creatinine. WOCN General Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for

the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Process Review health history to address risk factors

for LEND; CD-4 and HIV viral loads. WOCN General

Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Process Review health history to address risk factors for LEND; Creactive protein, erythrocyte

sediment rate. WOCN General

Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Process Review health history to address risk factors

for LEND; Thyroid stimulating hormone. WOCN General

Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Outcome

Interventions for Patients With LEND and Ulcers; Maintain dry, stable eschar on noninfected, ischemic,

neuropathic wounds.

WOCN Foot and

Ankle Care Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for

the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Process

Interventions for Patients With LEND and Ulcers; Consider use of Vitamin B-12 which may prevent peripheral neuropathic

symptoms.

WOCN General

Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Process

Interventions for Patients With LEND and Ulcers; Monitory for vitamin D deficiency which has been reported in patients with peripheral neuropathy symptoms.

WOCN General

(2)

Crawford, P. E. and M. Fields-Varnado (2013). "Guideline for the management of wounds in patients with lower-extremity neuropathic disease: an executive summary." J Wound Ostomy Continence Nurs 40(1): 34-45.

ECC Process

Adjunctive Treatments for Patients with LEND and Ulcers; Refer patients who smoke and have loss of protective sensation to foot care specialists, and include smoking cessation education and counseling.

WOCN General

Lipsky, B. A., et al. (2012). "2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections." Clin Infect Dis 54(12):

e132-173.

ECC Process

Clinicians should select and routinely use a validated classification system, such as that developed by the International Working Group on the Diabetic Foot (IWGDF) (abbreviated with the acronym PEDIS) or IDSA (see below), to classify infections and to help define the mix of types and severity of their cases and their outcomes

IDSA Foot and

Ankle Care

Lipsky, B. A., et al. (2012). "2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections." Clin Infect Dis 54(12):

e132-173.

ECC Process

[Redistribution of pressure off the wound to the entire weight-bearing surface of the foot (“off-loading”).]

While particularly important for plantar wounds, this is also necessary to relieve pressure caused by dressings, footwear, or ambulation to any surface of the wound (strong, high).

IDSA Foot and

Ankle Care

Fox, N., et al. (2012). "Evaluation and management of penetrating lower extremity arterial trauma: An eastern association for the surgery of trauma practice management guideline." Journal of Trauma and Acute Care Surgery 73(5 SUPPL.4): S315-S320.

ECC Process

Computed tomographic angiography (CTA) may be used as the primary diagnostic study for evaluation of penetrating lower extremity vascular injury when imaging is required.

EAST Foot and

Ankle Care

Korean Society for, C., et al. (2014). "Clinical guidelines for the antimicrobial treatment of bone and joint infections in

Korea." Infect Chemother 46(2): 125-138. ECC Process

In cases of acute osteomyelitis, appropriate antimicrobial agents should be given promptly to limit bacteremia, bone necrosis and bone destruction.

KSC, KSID, KOA General

Korean Society for, C., et al. (2014). "Clinical guidelines for the antimicrobial treatment of bone and joint infections in Korea." Infect Chemother 46(2): 125-138.

ECC Process

5. Surgical modalities and duration of antimicrobial agents are determined based on the Cierny-Mader's classification. In general, we recommend antimicrobial treatment of 4–6 weeks after the last major debridement.

However, treatment must be tailored according to the stage and condition of the individual patient.

KSC, KSID, KOA General

(3)

Korean Society for, C., et al. (2014). "Clinical guidelines for the antimicrobial treatment of bone and joint infections in

Korea." Infect Chemother 46(2): 125-138. ECC Process

In cases of community-acquired osteomyelitis, nafcillin or cefazolin is recommended as an empirical agent, given that the most commonly isolated organism is methicillin- susceptible S. aureus (MSSA).

KSC, KSID, KOA General

Korean Society for, C., et al. (2014). "Clinical guidelines for the antimicrobial treatment of bone and joint infections in

Korea." Infect Chemother 46(2): 125-138. ECC Process Nafcillin or cefazolin should be administrated

to treat osteomyelitis caused by MSSA. KSC, KSID, KOA General

NQF QPS CCC Process Communication with the physician or other

clinician managing on-going care post fracture

for men and women aged 50 years and older. NQF #0045, NCQA General

NQF QPS CCC Process

Osteoporosis Management in Women Who Had a Fracture

The percentage of women age 50-85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis in the six months after the fracture.

NQF #0053, NCQA General

CMS PQRS, AHRQ NQMC, NQF QPS ECC Process

Diabetes: Foot Exam: The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who received a foot exam (visual inspection and sensory exam with mono filament and a pulse exam) during the measurement year.

NQF #0056, PQRS

#163, NCQA Foot and

Ankle Care

AHRQ NQMC, NQF QPS C/PH; P/S Process

Falls: Screening, Risk-Assessment, and Plan of Care to Prevent Future Falls: This is a clinical process measure that assesses falls prevention in older adults. The measure has three rates: A) Screening for Future Fall Risk:

Percentage of patients aged 65 years of age and older who were screened for future fall risk at least once within 12 months; B) Falls:

Risk Assessment: Percentage of patients aged 65 years of age and older with a history of falls who had a risk assessment for falls completed within 12 months; C) Plan of Care for Falls: Percentage of patients aged 65 years of age and older with a history of falls who had a plan of care for falls documented within 12 months.

NQF #0101, NCQA General

(4)

AHRQ NQMC, NQF QPS PS Process

Surgery Patients Who Received Appropriate Venous Thromboembolism Prophylaxis Within 24 Hours Prior to Surgery to 24 Hours After Surgery

NQF #0218, CMS General

NQF QPS CCC Outcome

Lower-Extremity Amputation among Patients with Diabetes Rate (PQI 16)

Admissions for any-listed diagnosis of diabetes and any-listed procedure of lower- extremity amputation per 100,000 population, ages 18 years and older. Excludes any-listed diagnosis of traumatic lower-extremity amputation admissions, toe amputation admission (likely to be traumatic), obstetric admissions, and transfers from other institutions.

NQF #0285, AHRQ Foot and Ankle Care

CMS PQRS, AHRQ NQMC, NQF QPS

ECC, PCCEO

(2°) Process

Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear: Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who were evaluated for proper footwear and sizing during one or more office visits within 12 month

NQF #0416, PQRS

#127, APMA Foot and

Ankle Care

CMS PQRS, AHRQ NQMC, NQF QPS ECC Process

Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation: Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months

NQF #0417, PQRS

#126, APMA

Foot and Ankle Care

CMS PQRS, AHRQ NQMC, NQF QPS CCC Outcome

Functional status change for patients with foot/ankle impairments: Functional status change in patients aged 18 or older with a foot/ankle impairment associated with a functional deficit that had their functional status assessed at the beginning and end of rehabilitation

NQF #0424, CMS

#219, Focus on Therapeutic Outcomes,

Inc.

Foot and Ankle Care

AHRQ NQMC, NQF QPS PCCEO,

CCC, ECC (2°)

Process

Diabetic Foot Care and Patient Education Implemented: Percentage of home health episodes of care in which diabetic foot care and patient/caregiver education were included in the physician-ordered plan of care and implemented for diabetic patients since the previous OASIS assessment.

NQF #0519, CMS Foot and Ankle Care

(5)

AHRQ NQMC PS, CCC

(2°) Process

Diabetic Foot Care and Patient Education in Plan of Care: Percentage of home health episodes of care in which the physician- ordered plan of care includes regular

monitoring for the presence of skin lesions on the lower extremities and patient education on proper diabetic foot care.

CMS Foot and

Ankle Care

AHRQ NQMC CCC,

PCCEO (2°)

Process

Diabetic Foot Care And Patient/Caregiver Education Implemented During Long Term Episodes Of Care: Percentage of long term home health episodes of care during which diabetic foot care and education were included in the physician-ordered plan of care and implemented (since the previous OASIS assessment).

CMS Foot and

Ankle Care

Abbreviations:

WOCN: Wound, Ostomy and Continence Nurses Society; IDSA: Infectious Diseases Society of America; EAST: Eastern Association for the Surgery of Trauma; KSC: Korean Society for Chemotherapy; KSID: Korean Society of Infectious Disease; KOA: Korean Orthopaedic Association; NCQA: National Committee for Quality Assurance; CMS: Centers for Medicare & Medicaid Services;

APMA: American Podiatric Medical Association

Referensi

Dokumen terkait